We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+33.27%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$273M
AUM Growth
+$22.8M
Cap. Flow
+$4.67M
Cap. Flow %
1.71%
Top 10 Hldgs %
26.58%
Holding
166
New
40
Increased
8
Reduced
21
Closed
31

Top Buys

Rank Stock Value
1
BLRX
BioLineRX
BLRX
+$5.92M
2
PLRX icon
Pliant Therapeutics
PLRX
+$4.11M
3
NSTG
NanoString Technologies, Inc.
NSTG
+$3.89M
4
RMD icon
ResMed
RMD
+$3.87M
5
BCAB icon
BioAtla
BCAB
+$3.62M

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$5.32M
2
LNTH icon
Lantheus
LNTH
+$3.48M
3
ESPR
Esperion Therapeutics
ESPR
+$3.45M
4
DXCM icon
DexCom
DXCM
+$3.28M
5
LIVN icon
LivaNova
LIVN
+$3.12M

Sector Composition

Rank Sector Weight
1 Healthcare 79.05%
2 Financials 10.08%
3 Industrials 0.61%
4 Consumer Staples 0.24%
5 Communication Services 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNTC icon
101
Benitec Biopharma
BNTC
$468M
$245K 0.09%
+38,753
New +$492K
VEEE icon
102
Twin Vee PowerCats
VEEE
$4.85M
$165K 0.06%
+183
New +$266K
VIGL
103
DELISTED
Vigil Neuroscience
VIGL
$144K 0.05%
+15,788
New +$116K
SDEV
104
Stablecoin Development Corp
SDEV
$52M
$121K 0.04%
+179
New +$249K
ZEV.WS
105
DELISTED
Lightning eMotors, Inc. Redeemable Warrants, each whole warrant exercisable 1/20th of a share of common stock at an exercise price of $230.00 per whole share
ZEV.WS
$120K 0.04%
652,173
– –
TCBPW
106
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$118K 0.04%
941,176
– –
HCDIZ
107
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
$114K 0.04%
650,000
– –
OBIO icon
108
Orchestra BioMed
OBIO
$254M
$99K 0.04%
10,000
– –
HCDIW
109
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIW
$91K 0.03%
600,000
– –
NXGLW icon
110
NexGel Inc Warrant
NXGLW
$68K 0.02%
225,000
– –
LUCYW icon
111
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$123K
$60K 0.02%
+150,000
New +$98.9K
CINGW icon
112
Cingulate Inc Warrants
CINGW
$33.2K
$59K 0.02%
270,000
– –
RCOR.WS
113
DELISTED
Renovacor, Inc. Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11. 50 per whole share
RCOR.WS
$58K 0.02%
731,561
– –
BRSHW
114
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$52K 0.02%
+120,193
New +$55.3K
DRCTW
115
DELISTED
Direct Digital Holdings, Inc. Warrant
DRCTW
$49K 0.02%
180,000
– –
NLSPW
116
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$43K 0.02%
200,000
– –
NEXRW
117
Nexera Technologies Ltd Warrant
NEXRW
$48.9K
$40K 0.01%
+240,385
New +$66.2K
BNCWW
118
CEA Industries Inc Warrant
BNCWW
$38K 0.01%
250,000
– –
ONFOW icon
119
Onfolio Holdings Warrant
ONFOW
$64.5K
$30K 0.01%
+200,000
New +$35.4K
LAAAW
120
DELISTED
Lakeshore Acquisition I Corp. Warrant
LAAAW
$30K 0.01%
150,000
– –
PEPLW
121
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$27K 0.01%
367,500
– –
MBTCR
122
DELISTED
Nocturne Acquisition Corporation Right
MBTCR
$22K 0.01%
500,000
– –
NXLIW
123
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$19K 0.01%
+105,000
New +$21K
SRZNW icon
124
Surrozen Inc Warrant
SRZNW
$8.86K
$15K 0.01%
82,233
– –
MOBXW icon
125
Mobix Labs Warrants
MOBXW
$752K
$7K ﹤0.01%
150,000
– –
3 4
5
6 7

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Altium Capital Management held 166 positions worth $273M, up 9.1% from $250M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Altium Capital Management's Q3 2022 filing shows 40 new, 8 increased, 21 reduced and 31 closed positions. Its largest new stake was BioLineRX: 103,732 shares worth $3.84M. The largest sale was STAAR Surgical, an estimated $5.32M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 74% a quarter earlier, followed by Financials and Industrials.

  • Altium Capital Management's largest Q3 2022 buy was BioLineRX: 103,732 shares worth $3.84M.
  • Altium Capital Management added most to AngioDynamics in Q3 2022, an estimated $3.41M increase.
  • Altium Capital Management's biggest Q3 2022 reduction was Lantheus, cutting an estimated $3.48M.
  • Altium Capital Management fully exited STAAR Surgical in Q3 2022, selling an estimated $5.32M.
  • Altium Capital Management's ten largest holdings make up 27% of its $273M portfolio in Q3 2022.
  • Altium Capital Management opened 40 new positions and closed 31 in Q3 2022.
  • Altium Capital Management's portfolio value rose 9.1% quarter-over-quarter to $273M.

Based on Altium Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.